US-based biotechnology company Novavax's protein-based vaccine has shown overall 90 per cent effica…

"Some unprofitable growth companies will need to raise capital externally in order to remain solven…

These are Business Insider's biggest healthcare stories for January 27.

Business Insider asked 12 investors which startups they think are ready to break out in the next 12…

A phase 2 trial of a Covid-19 vaccine candidate conducted in China has found that the vaccine i…

Especially in today's climate, where the pandemic has taken over the world, it is imperative tha…

Jaipur, Jan 10 () A biotechnology park and incubation centre will be set up in Rajasthan for which …

Chairman Jerome Powell could speed up the taper of the Fed's monthly bond purchases and reveal when…

Fed Chairman Jerome Powell could speed up its monthly bond purchase tapering program as it seeks to…

The world is watching Moderna, in hopes that its coronavirus vaccine can help halt the pandemic. It…

The coronavirus crisis is changing the global dynamics of power and where India stands in the globa…

Indian Institute of Technology (IIT) Hyderabad on Wednesday said its researchers have found a molec…

Pfizer had originally invested $25 million in Trillium in September of last year, as part of its br…

As some high-profile SPACs have imploded or fallen afoul of regulators, investors have increasingly…

"Inflation is being pushed higher on supply chain issues and pent-up consumer spending, all of whic…

Orphazyme surged in the US Thursday as the stock received chatter from Redditors on Wall Street Bet…

The FDA approval marks the first treatment cleared by US regulators to decelerate cognitive decline…

The latest additions build on Palihapitiya's roster of 6 special-purpose acquisition companies alre…

The same companies comprised the top five in the bank's hedge fund VIP list: Facebook, Microsoft, A…

Apart from this, the FDA will give the company access to more frequent meetings and may even grant …